{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:29:48Z","timestamp":1792020588850,"version":"4.4.0"},"reference-count":127,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T00:00:00Z","timestamp":1515974400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["CREST"],"award-info":[{"award-number":["CREST"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["KAKENHI Grant-in-Aid for Scientific Research C 15K07166, KAKENHI Grant-in-Aid for Scientific Research B (Generative Research Fields) 16KT0111, KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas 17H05813, Core-to-Core program, A. Advanced Research Networks"],"award-info":[{"award-number":["KAKENHI Grant-in-Aid for Scientific Research C 15K07166, KAKENHI Grant-in-Aid for Scientific Research B (Generative Research Fields) 16KT0111, KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas 17H05813, Core-to-Core program, A. Advanced Research Networks"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Salt Science Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["Japanese Initiative for Progress of Research on Infectious Disease for global Epidemic (J-PRIDE) 17fm0208006h0001, Research on HIV\/AIDS 16fk0410203h002"],"award-info":[{"award-number":["Japanese Initiative for Progress of Research on Infectious Disease for global Epidemic (J-PRIDE) 17fm0208006h0001, Research on HIV\/AIDS 16fk0410203h002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01823","type":"journal-article","created":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T11:06:21Z","timestamp":1516014381000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":96,"title":["Type I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control"],"prefix":"10.3389","volume":"8","author":[{"given":"Andrew","family":"Soper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumpei","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoriyuki","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,1,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11904-014-0244-6","article-title":"Type I interferon: understanding its role in HIV pathogenesis and therapy","volume":"12","author":"Bosinger","year":"2015","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrmicro3449","article-title":"HIV-1 and interferons: who\u2019s interfering with whom?","volume":"13","author":"Doyle","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.20411\/pai.v1i1.125","article-title":"Interferons and HIV infection: the good, the bad, and the ugly","volume":"1","author":"Utay","year":"2016","journal-title":"Pathog Immun"},{"key":"B4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00418-002-0485-0","article-title":"Expression of IFI 16 in epithelial cells and lymphoid tissues","volume":"119","author":"Wei","year":"2003","journal-title":"Histochem Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"E4571","DOI":"10.1073\/pnas.1311669110","article-title":"IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication","volume":"110","author":"Jakobsen","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e84513","DOI":"10.1371\/journal.pone.0084513","article-title":"T cells detect intracellular DNA but fail to induce type I IFN responses: implications for restriction of HIV replication","volume":"9","author":"Berg","year":"2014","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.4049\/jimmunol.1402066","article-title":"Positive feedback regulation of type I IFN production by the IFN-inducible DNA sensor cGAS","volume":"194","author":"Ma","year":"2015","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.immuni.2013.11.002","article-title":"The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells","volume":"39","author":"Lahaye","year":"2013","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1126\/science.1240933","article-title":"Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses","volume":"341","author":"Gao","year":"2013","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.4049\/jimmunol.1400952","article-title":"HIV-1 single-stranded RNA induces CXCL13 secretion in human monocytes via TLR7 activation and plasmacytoid dendritic cell-derived type I IFN","volume":"194","author":"Cohen","year":"2015","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1182\/blood-2009-04-216770","article-title":"TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN","volume":"114","author":"Di Domizio","year":"2009","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1001284","DOI":"10.1371\/journal.ppat.1001284","article-title":"Innate sensing of HIV-infected cells","volume":"7","author":"Lepelley","year":"2011","journal-title":"PLoS Pathog"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1172\/JCI26032","article-title":"Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions","volume":"115","author":"Beignon","year":"2005","journal-title":"J Clin Invest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"13631","DOI":"10.1073\/pnas.250477397","article-title":"IFNalpha\/beta promotes cell survival by activating NF-kappa B","volume":"97","author":"Yang","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.biochi.2007.05.001","article-title":"Interferon, a growing cytokine family: 50 years of interferon research","volume":"89","author":"Chelbi-Alix","year":"2007","journal-title":"Biochimie"},{"key":"B17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1126\/science.2470148","article-title":"Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines","volume":"244","author":"Poli","year":"1989","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nature10623","article-title":"HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase","volume":"480","author":"Goldstone","year":"2011","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nature10117","article-title":"SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx","volume":"474","author":"Laguette","year":"2011","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nature10195","article-title":"Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein","volume":"474","author":"Hrecka","year":"2011","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.virol.2012.11.010","article-title":"Intracellular nucleotide levels and the control of retroviral infections","volume":"436","author":"Amie","year":"2013","journal-title":"Virology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1038\/nm.2964","article-title":"SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells","volume":"18","author":"Baldauf","year":"2012","journal-title":"Nat Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.15252\/embj.201696025","article-title":"G1-like state allows HIV-1 to bypass SAMHD1 restriction in macrophages","volume":"36","author":"Mlcochova","year":"2017","journal-title":"EMBO J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1038\/onc.2009.170","article-title":"Mammalian cell-cycle regulation: several CDKs, numerous cyclins and diverse compensatory mechanisms","volume":"28","author":"Satyanarayana","year":"2009","journal-title":"Oncogene"},{"key":"B25","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.chom.2015.05.010","article-title":"Subversion of cell cycle regulatory mechanisms by HIV","volume":"17","author":"Rice","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/rmv.1739","article-title":"Comparing HIV-1 and HIV-2 infection: lessons for viral immunopathogenesis","volume":"23","author":"Nyamweya","year":"2013","journal-title":"Rev Med Virol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.chom.2013.06.002","article-title":"Gene loss and adaptation to hominids underlie the ancient origin of HIV-1","volume":"14","author":"Etienne","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B28","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/nm.3626","article-title":"The ribonuclease activity of SAMHD1 is required for HIV-1 restriction","volume":"20","author":"Ryoo","year":"2014","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.virol.2015.03.012","article-title":"APOBECs and virus restriction","volume":"47","author":"Harris","year":"2015","journal-title":"Virology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1128\/JVI.01976-08","article-title":"Guidelines for naming nonprimate APOBEC3 genes and proteins","volume":"83","author":"LaRue","year":"2009","journal-title":"J Virol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"9546","DOI":"10.1128\/JVI.00823-10","article-title":"Remarkable lethal G-to-A mutations in Vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice","volume":"84","author":"Sato","year":"2010","journal-title":"J Virol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1004453","DOI":"10.1371\/journal.ppat.1004453","article-title":"APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model","volume":"10","author":"Sato","year":"2014","journal-title":"PLoS Pathog"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.1128\/JVI.00062-14","article-title":"Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation","volume":"88","author":"Kobayashi","year":"2014","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1002800","DOI":"10.1371\/journal.ppat.1002800","article-title":"Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n","volume":"8","author":"Refsland","year":"2012","journal-title":"PLoS Pathog"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.cub.2004.06.050","article-title":"APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo","volume":"14","author":"Liddament","year":"2004","journal-title":"Curr Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e1006348","DOI":"10.1371\/journal.ppat.1006348","article-title":"HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation","volume":"13","author":"Nakano","year":"2017","journal-title":"PLoS Pathog"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1004761","DOI":"10.1371\/journal.pgen.1004761","article-title":"Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity","volume":"10","author":"Refsland","year":"2014","journal-title":"PLoS Genet"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1128\/JVI.02049-10","article-title":"Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity","volume":"85","author":"Wang","year":"2011","journal-title":"J Virol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.chom.2008.07.005","article-title":"Antiretroelement activity of APOBEC3H was lost twice in recent human evolution","volume":"4","author":"OhAinle","year":"2008","journal-title":"Cell Host Microbe"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1128\/MCB.9.11.5062","article-title":"cDNA structures and regulation of two interferon-induced human Mx proteins","volume":"9","author":"Aebi","year":"1989","journal-title":"Mol Cell Biol"},{"key":"B41","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/S0021-9258(18)89654-5","article-title":"An interferon-induced mouse protein involved in the mechanism of resistance to influenza viruses. Its purification to homogeneity and characterization by polyclonal antibodies","volume":"260","author":"Horisberger","year":"1985","journal-title":"J Biol Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nature12653","article-title":"MX2 is an interferon-induced inhibitor of HIV-1 infection","volume":"502","author":"Kane","year":"2013","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.chom.2013.08.015","article-title":"The interferon-inducible MxB protein inhibits HIV-1 infection","volume":"14","author":"Liu","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B44","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12542","article-title":"Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection","volume":"502","author":"Goujon","year":"2013","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1128\/JVI.75.6.2684-2691.2001","article-title":"Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein","volume":"75","author":"Gordien","year":"2001","journal-title":"J Virol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"9254","DOI":"10.1128\/JVI.00854-10","article-title":"Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells","volume":"84","author":"Goujon","year":"2010","journal-title":"J Virol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coviro.2013.11.003","article-title":"A model for cofactor use during HIV-1 reverse transcription and nuclear entry","volume":"4","author":"Hilditch","year":"2014","journal-title":"Curr Opin Virol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"12779","DOI":"10.1074\/jbc.M115.650325","article-title":"Role of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity","volume":"290","author":"Dick","year":"2015","journal-title":"J Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nature11433","article-title":"Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11","volume":"491","author":"Li","year":"2012","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1006066","DOI":"10.1371\/journal.ppat.1006066","article-title":"Non-human primate schlafen11 inhibits production of both host and viral proteins","volume":"12","author":"Stabell","year":"2016","journal-title":"PLoS Pathog"},{"key":"B51","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.chom.2012.09.007","article-title":"IFN-inducible GTPases in host cell defense","volume":"12","author":"Kim","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B52","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.chom.2016.02.019","article-title":"Guanylate binding protein (GBP) 5 is an interferon-inducible inhibitor of HIV-1 infectivity","volume":"19","author":"Krapp","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B53","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature06553","article-title":"Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu","volume":"451","author":"Neil","year":"2008","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.chom.2008.03.001","article-title":"The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein","volume":"3","author":"Van Damme","year":"2008","journal-title":"Cell Host Microbe"},{"key":"B55","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/313277a0","article-title":"Complete nucleotide sequence of the AIDS virus, HTLV-III","volume":"313","author":"Ratner","year":"1985","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1089\/aid.1987.3.57","article-title":"Complete nucleotide sequences of functional clones of the AIDS virus","volume":"3","author":"Ratner","year":"1987","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0092-8674(86)90860-3","article-title":"Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients","volume":"46","author":"Alizon","year":"1986","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0378-1119(87)90396-9","article-title":"Molecular characterization of human immunodeficiency virus from Zaire: nucleotide sequence analysis identifies conserved and variable domains in the envelope gene","volume":"52","author":"Srinivasan","year":"1987","journal-title":"Gene"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1371\/journal.ppat.0020039","article-title":"HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane","volume":"2","author":"Neil","year":"2006","journal-title":"PLoS Pathog"},{"key":"B60","doi-asserted-by":"publisher","first-page":"15154","DOI":"10.1073\/pnas.2433165100","article-title":"Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production","volume":"100","author":"Varthakavi","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B61","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.1073\/pnas.90.15.7381","article-title":"Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses","volume":"90","author":"Gottlinger","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B62","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1128\/JVI.64.2.621-629.1990","article-title":"The human immunodeficiency virus type 1-specific protein Vpu is required for efficient virus maturation and release","volume":"64","author":"Klimkait","year":"1990","journal-title":"J Virol"},{"key":"B63","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1128\/JVI.63.9.3784-3791.1989","article-title":"Molecular and biochemical analyses of human immunodeficiency virus type 1 Vpu protein","volume":"63","author":"Strebel","year":"1989","journal-title":"J Virol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1073\/pnas.86.13.5163","article-title":"Functional role of human immunodeficiency virus type 1 Vpu","volume":"86","author":"Terwilliger","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B65","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1034\/j.1600-0854.2003.00129.x","article-title":"BST-2\/HM1.24 is a raft-associated apical membrane protein with an unusual topology","volume":"4","author":"Kupzig","year":"2003","journal-title":"Traffic"},{"key":"B66","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cell.2009.08.039","article-title":"Tetherin inhibits HIV-1 release by directly tethering virions to cells","volume":"139","author":"Perez-Caballero","year":"2009","journal-title":"Cell"},{"key":"B67","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1742-4690-6-53","article-title":"Comparative study on the effect of human BST-2\/tetherin on HIV-1 release in cells of various species","volume":"6","author":"Sato","year":"2009","journal-title":"Retrovirology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1177\/1535370217697384","article-title":"Various plus unique: viral protein U as a plurifunctional protein for HIV-1 replication","volume":"242","author":"Soper","year":"2017","journal-title":"Exp Biol Med (Maywood)"},{"key":"B69","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1128\/JVI.01668-10","article-title":"Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility","volume":"85","author":"Kobayashi","year":"2011","journal-title":"J Virol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"12958","DOI":"10.1128\/JVI.01699-10","article-title":"Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein","volume":"84","author":"Vigan","year":"2010","journal-title":"J Virol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"35060","DOI":"10.1074\/jbc.M109.058305","article-title":"HIV-1 accessory protein Vpu internalizes cell-surface BST-2\/tetherin through transmembrane interactions leading to lysosomes","volume":"284","author":"Iwabu","year":"2009","journal-title":"J Biol Chem"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e1001265","DOI":"10.1371\/journal.ppat.1001265","article-title":"The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2\/tetherin down-regulation","volume":"7","author":"Janvier","year":"2011","journal-title":"PLoS Pathog"},{"key":"B73","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1128\/JVI.07062-11","article-title":"Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice","volume":"86","author":"Sato","year":"2012","journal-title":"J Virol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1742-4690-10-128","article-title":"Efficient BST2 antagonism by Vpu is critical for early HIV-1 dissemination in humanized mice","volume":"10","author":"Dave","year":"2013","journal-title":"Retrovirology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.chom.2012.10.007","article-title":"Innate sensing of HIV-1 assembly by tetherin induces NF\u03baB-dependent proinflammatory responses","volume":"12","author":"Galao","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B76","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.celrep.2014.12.047","article-title":"Differential regulation of NF-\u03baB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins","volume":"10","author":"Sauter","year":"2015","journal-title":"Cell Rep"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1128\/JVI.02272-12","article-title":"Stimulation of NF-kappaB activity by the HIV restriction factor BST2","volume":"87","author":"Tokarev","year":"2013","journal-title":"J Virol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11904-007-0005-x","article-title":"Current concepts of HIV transmission","volume":"4","author":"Morrow","year":"2007","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B79","doi-asserted-by":"publisher","first-page":"E590","DOI":"10.1073\/pnas.1620144114","article-title":"Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness","volume":"114","author":"Iyer","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B80","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1742-4690-10-146","article-title":"Relative resistance of HIV-1 founder viruses to control by interferon-alpha","volume":"10","author":"Fenton-May","year":"2013","journal-title":"Retrovirology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"6626","DOI":"10.1073\/pnas.1304288110","article-title":"Phenotypic properties of transmitted founder HIV-1","volume":"110","author":"Parrish","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B82","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-1-4614-4433-6_3","article-title":"Plasmacytoid dendritic cells in HIV infection","volume":"762","author":"O\u2019Brien","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1172\/JCI44960","article-title":"Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-alpha-producing and partially matured phenotype","volume":"121","author":"O\u2019Brien","year":"2011","journal-title":"J Clin Invest"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1099\/0022-1317-81-10-2341","article-title":"Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures","volume":"81","author":"Goodbourn","year":"2000","journal-title":"J Gen Virol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"key":"B86","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0163-7258(93)90021-5","article-title":"Human natural interferon-alpha producing cells","volume":"60","author":"Fitzgerald-Bocarsly","year":"1993","journal-title":"Pharmacol Ther"},{"key":"B87","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/QAD.0000000000001380","article-title":"IFN-alpha augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation","volume":"31","author":"Tomescu","year":"2017","journal-title":"AIDS"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1097\/QAD.0000000000000777","article-title":"Lysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D","volume":"29","author":"Tomescu","year":"2015","journal-title":"AIDS"},{"key":"B89","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/01.aids.0000050816.06065.b1","article-title":"Interferon-alpha restores HIV-induced alteration of natural killer cell perforin expression in vivo","volume":"17","author":"Portales","year":"2003","journal-title":"AIDS"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-2478(97)00091-6","article-title":"Type I interferons enhance production of IFN-gamma by NK cells","volume":"59","author":"Hunter","year":"1997","journal-title":"Immunol Lett"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e00972-17","DOI":"10.1128\/JVI.00972-17","article-title":"Interferon-inducible CD169\/Siglec1 attenuates anti-HIV-1 effects of IFN-alpha","volume":"91","author":"Akiyama","year":"2017","journal-title":"J Virol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/infdis\/jit612","article-title":"Longitudinal analysis of distribution and function of plasmacytoid dendritic cells in peripheral blood and gut mucosa of HIV infected patients","volume":"209","author":"Lehmann","year":"2014","journal-title":"J Infect Dis"},{"key":"B93","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/imm.12132","article-title":"Multi-functional plasmacytoid dendritic cells redistribute to gut tissues during simian immunodeficiency virus infection","volume":"140","author":"Li","year":"2013","journal-title":"Immunology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1600-0684.2010.00428.x","article-title":"In acute pathogenic SIV infection plasmacytoid dendritic cells are depleted from blood and lymph nodes despite mobilization","volume":"39","author":"Barratt-Boyes","year":"2010","journal-title":"J Med Primatol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e94512","DOI":"10.1371\/journal.pone.0094512","article-title":"PEG-IFN alpha but not ribavirin alters NK cell phenotype and function in patients with chronic hepatitis C","volume":"9","author":"Markova","year":"2014","journal-title":"PLoS One"},{"key":"B96","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.it.2003.10.012","article-title":"NK cell and DC interactions","volume":"25","author":"Cooper","year":"2004","journal-title":"Trends Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/35095564","article-title":"Natural killer cells, viruses and cancer","volume":"1","author":"Cerwenka","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"B99","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0065-2776(08)60664-1","article-title":"Biology of natural killer cells","volume":"47","author":"Trinchieri","year":"1989","journal-title":"Adv Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e11110","DOI":"10.1371\/journal.pone.0011110","article-title":"Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients","volume":"5","author":"Lehmann","year":"2010","journal-title":"PLoS One"},{"key":"B101","doi-asserted-by":"publisher","first-page":"7000","DOI":"10.1073\/pnas.0600363103","article-title":"Differential expression of IFN-alpha and TRAIL\/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients","volume":"103","author":"Herbeuval","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/mi.2015.146","article-title":"Prevention of SHIV transmission by topical IFN-beta treatment","volume":"9","author":"Veazey","year":"2016","journal-title":"Mucosal Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1749-6632.1984.tb37163.x","article-title":"Malignancies in the AIDS patient: natural history, treatment strategies, and preliminary results","volume":"437","author":"Longo","year":"1984","journal-title":"Ann N Y Acad Sci"},{"key":"B104","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1128\/JVI.07114-11","article-title":"Plasmacytoid dendritic cells reduce HIV production in elite controllers","volume":"86","author":"Machmach","year":"2012","journal-title":"J Virol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.1128\/JVI.00451-16","article-title":"Interferon alpha subtype-specific suppression of HIV-1 infection in vivo","volume":"90","author":"Lavender","year":"2016","journal-title":"J Virol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e1005254","DOI":"10.1371\/journal.ppat.1005254","article-title":"Interferon-alpha subtypes in an ex vivo model of acute HIV-1 infection: expression, potency and effector mechanisms","volume":"11","author":"Harper","year":"2015","journal-title":"PLoS Pathog"},{"key":"B107","doi-asserted-by":"publisher","first-page":"78412","DOI":"10.18632\/oncotarget.12512","article-title":"Gene therapy with plasmids encoding IFN-beta or IFN-alpha14 confers long-term resistance to HIV-1 in humanized mice","volume":"7","author":"Abraham","year":"2016","journal-title":"Oncotarget"},{"key":"B108","doi-asserted-by":"publisher","first-page":"7886","DOI":"10.1128\/JVI.02612-09","article-title":"Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques","volume":"84","author":"Harris","year":"2010","journal-title":"J Virol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"6264","DOI":"10.1128\/JVI.00563-15","article-title":"In vivo activation of human NK cells by treatment with an interleukin-15 superagonist potently inhibits acute in vivo HIV-1 infection in humanized mice","volume":"89","author":"Seay","year":"2015","journal-title":"J Virol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cellimm.2011.09.005","article-title":"Accumulation and activation of natural killer cells in local intraperitoneal HIV-1\/MuLV infection results in early control of virus infected cells","volume":"272","author":"Johansson","year":"2011","journal-title":"Cell Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"5750","DOI":"10.1182\/blood-2012-02-411496","article-title":"Treatment of SIV-infected sooty mangabeys with a type-I IFN agonist results in decreased virus replication without inducing hyperimmune activation","volume":"119","author":"Vanderford","year":"2012","journal-title":"Blood"},{"key":"B112","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1172\/JCI40093","article-title":"Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response","volume":"119","author":"Jacquelin","year":"2009","journal-title":"J Clin Invest"},{"key":"B113","doi-asserted-by":"publisher","first-page":"a007153","DOI":"10.1101\/cshperspect.a007153","article-title":"Nonpathogenic simian immunodeficiency virus infections","volume":"2","author":"Klatt","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"14830","DOI":"10.1038\/ncomms14830","article-title":"SRC family kinases FYN and LYN are constitutively activated and mediate plasmacytoid dendritic cell responses","volume":"8","author":"Dallari","year":"2017","journal-title":"Nat Commun"},{"key":"B115","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1128\/JVI.02433-07","article-title":"Plasmacytoid dendritic cell dynamics and alpha interferon production during simian immunodeficiency virus infection with a nonpathogenic outcome","volume":"82","author":"Diop","year":"2008","journal-title":"J Virol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2567.2007.02758.x","article-title":"Effect of SIVmac infection on plasmacytoid and CD1c+ myeloid dendritic cells in cynomolgus macaques","volume":"124","author":"Malleret","year":"2008","journal-title":"Immunology"},{"key":"B117","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.4049\/jimmunol.178.11.6958","article-title":"Parallel loss of myeloid and plasmacytoid dendritic cells from blood and lymphoid tissue in simian AIDS","volume":"178","author":"Brown","year":"2007","journal-title":"J Immunol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.virol.2007.03.055","article-title":"Disparate effects of acute and chronic infection with SIVmac239 or SHIV-89.6P on macaque plasmacytoid dendritic cells","volume":"365","author":"Reeves","year":"2007","journal-title":"Virology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e1000413","DOI":"10.1371\/journal.ppat.1000413","article-title":"Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection","volume":"5","author":"Brown","year":"2009","journal-title":"PLoS Pathog"},{"key":"B120","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1182\/blood-2008-06-162651","article-title":"Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression","volume":"112","author":"Malleret","year":"2008","journal-title":"Blood"},{"key":"B121","doi-asserted-by":"publisher","first-page":"14355","DOI":"10.1128\/JVI.79.22.14355-14370.2005","article-title":"The toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques","volume":"79","author":"Wang","year":"2005","journal-title":"J Virol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.1128\/JVI.79.14.9217-9227.2005","article-title":"Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus","volume":"79","author":"Miller","year":"2005","journal-title":"J Virol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"12164","DOI":"10.1128\/JVI.79.19.12164-12172.2005","article-title":"Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection","volume":"79","author":"Abel","year":"2005","journal-title":"J Virol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nature13554","article-title":"Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression","volume":"511","author":"Sandler","year":"2014","journal-title":"Nature"},{"key":"B125","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1172\/JCI89488","article-title":"Targeting type I interferon-mediated activation restores immune function in chronic HIV infection","volume":"127","author":"Zhen","year":"2017","journal-title":"J Clin Invest"},{"key":"B126","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1172\/JCI90745","article-title":"Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs","volume":"127","author":"Cheng","year":"2017","journal-title":"J Clin Invest"},{"key":"B127","doi-asserted-by":"publisher","first-page":"94366","DOI":"10.1172\/jci.insight.94366","article-title":"Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection","volume":"2","author":"Cheng","year":"2017","journal-title":"JCI Insight"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01823\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T15:18:46Z","timestamp":1660317526000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01823\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,15]]},"references-count":127,"alternative-id":["10.3389\/fimmu.2017.01823"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01823","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,15]]},"article-number":"1823"}}